Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.

In mid-2024, the patient underwent a kidney transplant. Though he was relatively young for a transplant, that’s not where he ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) traded up 8.6% on Thursday . The company traded as high as $0.77 and last traded at $0.73. 366,739 shares changed hands during mid-day trading, a decline ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

One concern with bispecific antibody therapies in community settings is managing adverse events, with emerging patterns ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.